Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a US-based pharmaceutical company dedicated to developing and commercializing innovative therapies for rare neuromuscular diseases. The company focuses on delivering much-needed medicines and enhancing the quality of life for patients globally by specializing in areas with high unmet medical needs.
Frequently asked questions
When did Catalyst Pharmaceuticals last report quarterly earnings?
Catalyst Pharmaceuticals last reported quarterly earnings on 5/11/2026 (Q1 2026). Earnings per share (EPS) came in at 0.50 USD.
How often has Catalyst Pharmaceuticals beaten expectations?
Catalyst Pharmaceuticals has beaten analyst EPS estimates in 4 of its last 4 evaluated quarters (beat rate: 100%).
How do I add the Catalyst Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.